Endo Net Income 2006-2020 | ENDP

Endo net income from 2006 to 2020. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Endo Annual Net Income
(Millions of US $)
2019 $-423
2018 $-1,031
2017 $-2,035
2016 $-3,347
2015 $-1,495
2014 $-721
2013 $-685
2012 $-740
2011 $188
2010 $259
2009 $266
2008 $255
2007 $227
2006 $138
2005 $202
Endo Quarterly Net Income
(Millions of US $)
2020-03-31 $130
2019-12-31 $-219
2019-09-30 $-79
2019-06-30 $-106
2019-03-31 $-19
2018-12-31 $-292
2018-09-30 $-173
2018-06-30 $-61
2018-03-31 $-505
2017-12-31 $-368
2017-09-30 $-97
2017-06-30 $-1,397
2017-03-31 $-174
2016-12-31 $-3,338
2016-09-30 $-219
2016-06-30 $344
2016-03-31 $-134
2015-12-31 $-118
2015-09-30 $-1,050
2015-06-30 $-250
2015-03-31 $-76
2014-12-31 $-53
2014-09-30 $-252
2014-06-30 $21
2014-03-31 $-437
2013-12-31 $-776
2013-09-30 $40
2013-06-30 $35
2013-03-31 $15
2012-12-31 $-716
2012-09-30 $54
2012-06-30 $9
2012-03-31 $-87
2011-12-31 $37
2011-09-30 $41
2011-06-30 $55
2011-03-31 $56
2010-12-31 $93
2010-09-30 $54
2010-06-30 $51
2010-03-31 $60
2009-12-31 $148
2009-09-30 $49
2009-06-30 $30
2009-03-31 $39
2008-12-31 $73
2008-09-30 $66
2008-06-30 $57
2008-03-31 $60
2007-12-31 $51
2007-09-30 $59
2007-06-30 $61
2007-03-31 $57
2006-12-31 $15
2006-09-30 $45
2006-06-30 $58
2006-03-31 $21
2005-12-31 $73
2005-09-30 $67
2005-06-30 $49
2005-03-31 $14
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.783B $2.914B
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.927B 37.42
Takeda Pharmaceutical (TAK) Japan $55.110B 9.66
Astellas Pharma (ALPMY) Japan $29.863B 15.13
Eisai (ESALY) Japan $24.541B 21.27
UCB SA (UCBJF) Belgium $23.292B 0.00
Merck (MKGAF) Germany $15.852B 20.79
Grifols, S.A (GRFS) Spain $12.782B 15.89
Neurocrine Biosciences (NBIX) United States $12.083B 55.84
Catalent (CTLT) United States $11.806B 45.64
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.486B 45.12
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $6.936B 31.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.952B 9.53
United Therapeutics (UTHR) United States $5.184B 9.82
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.605B 502.78
Nektar Therapeutics (NKTR) United States $4.412B 0.00
Evotec AG (EVTCY) Germany $4.090B 110.22
Hypermarcas (HYPMY) Brazil $3.857B 11.73
ChemoCentryx (CCXI) United States $3.816B 0.00
PTC Therapeutics (PTCT) United States $3.737B 0.00
FibroGen (FGEN) United States $3.734B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.518B 10.35
Pacira BioSciences (PCRX) United States $2.382B 48.74
Sage Therapeutics (SAGE) United States $2.305B 0.00
Cronos Group (CRON) Canada $2.159B 61.90
Corcept Therapeutics (CORT) United States $1.930B 19.14
Xencor (XNCR) United States $1.878B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.759B 0.00
USANA Health Sciences (USNA) United States $1.737B 17.81
Akebia Therapeutics (AKBA) United States $1.697B 0.00
Indivior (INVVY) United States $1.604B 19.91
Ironwood Pharmaceuticals (IRWD) United States $1.592B 12.18
Zogenix (ZGNX) United States $1.565B 0.00
Esperion Therapeutics (ESPR) United States $1.456B 0.00
Karyopharm Therapeutics (KPTI) United States $1.424B 0.00
Heron Therapeutics (HRTX) United States $1.399B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.350B 14.55
Theravance Biopharma (TBPH) Cayman Islands $1.335B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.107B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.007B 44.93
BioCryst Pharmaceuticals (BCRX) United States $0.958B 0.00
Tilray (TLRY) Canada $0.946B 0.00
ImmunoGen (IMGN) United States $0.814B 0.00
Molecular Templates (MTEM) United States $0.633B 0.00
Ardelyx (ARDX) United States $0.627B 0.00
Aerie Pharmaceuticals (AERI) United States $0.623B 0.00
Trillium Therapeutics (TRIL) Canada $0.622B 0.00
VAXART, INC (VXRT) United States $0.605B 0.00
Radius Health (RDUS) United States $0.603B 0.00
Collegium Pharmaceutical (COLL) United States $0.587B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.576B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.539B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.525B 12.70
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.485B 18.92
Flexion Therapeutics (FLXN) United States $0.482B 0.00
Siga Technologies (SIGA) United States $0.455B 0.00
DURECT (DRRX) United States $0.433B 0.00
TherapeuticsMD (TXMD) United States $0.429B 0.00
Harpoon Therapeutics (HARP) United States $0.417B 0.00
Ocular Therapeutix (OCUL) United States $0.401B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.395B 0.00
Organogenesis Holdings (ORGO) United States $0.376B 0.00
Calithera Biosciences (CALA) United States $0.371B 0.00
MEI Pharma (MEIP) United States $0.361B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.313B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.285B 0.00
PROFOUND MEDICL (PROF) Canada $0.285B 0.00
Altimmune (ALT) United States $0.264B 0.00
Lannett Co Inc (LCI) United States $0.258B 5.65
Oasmia Pharmaceutical AB (OASMY) Sweden $0.257B 0.00
Redhill Biopharma (RDHL) Israel $0.246B 0.00
CASI Pharmaceuticals (CASI) United States $0.242B 0.00
Taiwan Liposome (TLC) Taiwan $0.234B 0.00
Jounce Therapeutics (JNCE) United States $0.217B 5.17
KalVista Pharmaceuticals (KALV) United States $0.210B 0.00
Rafael Holdings (RFL) United States $0.202B 0.00
OptiNose (OPTN) United States $0.195B 0.00
IMV INC (IMV) Canada $0.183B 0.00
Nivalis Therapeutics (ALPN) United States $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.174B 22.95
Aquestive Therapeutics (AQST) United States $0.155B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.146B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.142B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.123B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
Otonomy (OTIC) United States $0.110B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.106B 0.00
CTI BioPharma (CTIC) United States $0.105B 0.00
Recro Pharma (REPH) United States $0.103B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.100B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.100B 0.00
Xeris Pharmaceuticals (XERS) United States $0.099B 0.00
MediWound (MDWD) Israel $0.098B 0.00
Onconova Therapeutics (ONTX) United States $0.097B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.092B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.089B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
Sundial Growers (SNDL) Canada $0.084B 0.00
Biomerica (BMRA) United States $0.082B 0.00
Heat Biologics (HTBX) United States $0.075B 0.00
Aclaris Therapeutics (ACRS) United States $0.073B 0.00
SCYNEXIS (SCYX) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.065B 0.00
Lipocine (LPCN) United States $0.065B 0.00
Infinity Pharmaceuticals (INFI) United States $0.060B 0.00
CV Sciences (CVSI) United States $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.82
PolarityTE (PTE) United States $0.048B 0.00
Natural Alternatives (NAII) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
IsoRay (ISR) United States $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.76
Opiant Pharmaceuticals (OPNT) United States $0.040B 85.64
GTx (ONCT) United States $0.040B 0.00
Novan (NOVN) United States $0.039B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.038B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.037B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.034B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.027B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 32.71
Shineco (TYHT) China $0.014B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Vical (BBI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00